A study to evaluate the effectiveness of an update of educational materials with respect to evaluation of monitoring of metabolic parameters
Objective assessment of metabolic monitoring in patients treated with Seroquel® or Seroquel® XR/quetiapine fumarate: use of IMS Disease Analyzer to assess physician behaviour in the UK and Germany
Study Type
OBSERVATIONAL
Enrollment
6,153
Determination whether physicians in the UK and Germany perform monitoring of patients treated with Seroquel® and Seroquel® XR including measurement of the following during patient encounters: weight at drug initiation and over the course of treatment.
Time frame: Over 6 months following the distribution of metabolic educational materials in the country
Monitoring of hyperlipidemia during patient encounters.
Time frame: Over 6 months following the distribution of metabolic educational materials in the country
Monitoring for signs and symptoms of hyperglycemia during patient encounters.
Time frame: Over 6 months following the distribution of metabolic educational materials in the country
Monitoring of blood glucose in patients with diabetes; monitoring of patients with risk factors for diabetes for worsening of glycemic control during patient encounters.
Time frame: Over 6 months following the distribution of metabolic educational materials in the country
Counseling patients on healthy eating, exercise and healthy lifestyle improvements during patient encounters.
Time frame: Over 6 months following the distribution of metabolic educational materials in the country
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.